Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Rytlewski JA"'
Autor:
Johnson SA; Adaptive Biotechnologies, Seattle, Washington, United States of America., Seale SL; Adaptive Biotechnologies, Seattle, Washington, United States of America., Gittelman RM; Adaptive Biotechnologies, Seattle, Washington, United States of America., Rytlewski JA; Adaptive Biotechnologies, Seattle, Washington, United States of America., Robins HS; Adaptive Biotechnologies, Seattle, Washington, United States of America., Fields PA; Adaptive Biotechnologies, Seattle, Washington, United States of America.
Publikováno v:
PloS one [PLoS One] 2021 Aug 30; Vol. 16 (8), pp. e0249484. Date of Electronic Publication: 2021 Aug 30 (Print Publication: 2021).
Autor:
Lai AY; Research and Development, G1 Therapeutics, Inc, Research Triangle Park, North Carolina, USA., Sorrentino JA; Research and Development, G1 Therapeutics, Inc, Research Triangle Park, North Carolina, USA jsorrentino@g1therapeutics.com., Dragnev KH; Department of Hematology and Oncology, Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA., Weiss JM; Division of Hematology and Oncology, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA., Owonikoko TK; Department of Hematology and Medical Oncology, Emory University Winship Cancer Institute, Atlanta, Georgia, USA., Rytlewski JA; Life Sciences Research, Adaptive Biotechnologies Corp, Seattle, Washington, USA., Hood J; Life Sciences Research, Adaptive Biotechnologies Corp, Seattle, Washington, USA., Yang Z; Research and Development, G1 Therapeutics, Inc, Research Triangle Park, North Carolina, USA., Malik RK; Research and Development, G1 Therapeutics, Inc, Research Triangle Park, North Carolina, USA., Strum JC; Research and Development, G1 Therapeutics, Inc, Research Triangle Park, North Carolina, USA., Roberts PJ; Research and Development, G1 Therapeutics, Inc, Research Triangle Park, North Carolina, USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2020 Oct; Vol. 8 (2).
Autor:
Palakurthi S; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Kuraguchi M; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Zacharek SJ; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Zudaire E; Janssen, Pharmaceutical Companies of Johnson & Johnson, Spring House, Pennsylvania., Huang W; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Bonal DM; Lurie Family Imaging Center, Dana-Farber Cancer Institute, Boston, Massachusetts., Liu J; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Dhaneshwar A; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., DePeaux K; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Gowaski MR; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Bailey D; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Regan SN; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Ivanova E; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Ferrante C; Janssen, Pharmaceutical Companies of Johnson & Johnson, Spring House, Pennsylvania., English JM; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Khosla A; PathAI, Boston, Massachusetts., Beck AH; PathAI, Boston, Massachusetts., Rytlewski JA; Adaptive Biotechnologies, Seattle, Washington., Sanders C; Adaptive Biotechnologies, Seattle, Washington., Laquerre S; Janssen, Pharmaceutical Companies of Johnson & Johnson, Spring House, Pennsylvania., Bittinger MA; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Kirschmeier PT; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts., Packman K; Janssen, Pharmaceutical Companies of Johnson & Johnson, Spring House, Pennsylvania., Janne PA; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Moy C; Janssen, Pharmaceutical Companies of Johnson & Johnson, Spring House, Pennsylvania., Wong KK; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Laura & Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York University, New York, New York., Verona RI; Janssen, Pharmaceutical Companies of Johnson & Johnson, Spring House, Pennsylvania. rverona@its.jnj.com mlorenzi@its.jnj.com., Lorenzi MV; Janssen, Pharmaceutical Companies of Johnson & Johnson, Spring House, Pennsylvania. rverona@its.jnj.com mlorenzi@its.jnj.com.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2019 Sep; Vol. 7 (9), pp. 1457-1471. Date of Electronic Publication: 2019 Jul 22.
Autor:
Khunger A; Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH, USA., Rytlewski JA; Adaptive Biotechnologies, Seattle, WA, USA., Fields P; Adaptive Biotechnologies, Seattle, WA, USA., Yusko EC; Adaptive Biotechnologies, Seattle, WA, USA., Tarhini AA; Department of Cutaneous Oncology, Moffitt Comprehensive Cancer Center, Tampa, Florida, USA.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2019 Aug 20; Vol. 8 (11), pp. e1652538. Date of Electronic Publication: 2019 Aug 20 (Print Publication: 2019).
Autor:
Agdashian D; Gastrointestinal Malignancies Section, Thoracic and GI Oncology Branch, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Building 10, Room 3B43, Bethesda, MD, 20892, USA., ElGindi M; Gastrointestinal Malignancies Section, Thoracic and GI Oncology Branch, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Building 10, Room 3B43, Bethesda, MD, 20892, USA., Xie C; Gastrointestinal Malignancies Section, Thoracic and GI Oncology Branch, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Building 10, Room 3B43, Bethesda, MD, 20892, USA., Sandhu M; Gastrointestinal Malignancies Section, Thoracic and GI Oncology Branch, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Building 10, Room 3B43, Bethesda, MD, 20892, USA., Pratt D; Laboratory of Pathology, Center for Cancer Research (CCR) National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Kleiner DE; Laboratory of Pathology, Center for Cancer Research (CCR) National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Figg WD; Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Rytlewski JA; Adaptive Biotechnologies, Seattle, WA, USA., Sanders C; Adaptive Biotechnologies, Seattle, WA, USA., Yusko EC; Adaptive Biotechnologies, Seattle, WA, USA., Wood B; Center for Interventional Oncology, Radiology and Imaging Sciences and Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA., Venzon D; Biostatistics and Data Management Section, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Brar G; Gastrointestinal Malignancies Section, Thoracic and GI Oncology Branch, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Building 10, Room 3B43, Bethesda, MD, 20892, USA., Duffy AG; Gastrointestinal Malignancies Section, Thoracic and GI Oncology Branch, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Building 10, Room 3B43, Bethesda, MD, 20892, USA., Greten TF; Gastrointestinal Malignancies Section, Thoracic and GI Oncology Branch, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Building 10, Room 3B43, Bethesda, MD, 20892, USA. tim.greten@nih.gov.; NCI CCR Liver Cancer Program, Bethesda, MD, USA. tim.greten@nih.gov., Korangy F; Gastrointestinal Malignancies Section, Thoracic and GI Oncology Branch, Center for Cancer Research, National Cancer Institute (NCI), National Institutes of Health (NIH), Building 10, Room 3B43, Bethesda, MD, 20892, USA.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2019 Apr; Vol. 68 (4), pp. 599-608. Date of Electronic Publication: 2019 Jan 28.
Autor:
Cloughesy TF; Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. tcloughesy@mednet.ucla.edu.; Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. tcloughesy@mednet.ucla.edu.; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA. tcloughesy@mednet.ucla.edu., Mochizuki AY; Division of Hematology/Oncology, Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Orpilla JR; Department of Neurosurgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Hugo W; Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Lee AH; Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA.; Department of Neurosurgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Davidson TB; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA.; Division of Hematology/Oncology, Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Wang AC; Department of Neurosurgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Ellingson BM; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA.; Department of Radiological Sciences, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Rytlewski JA; Adaptive Biotechnologies, Seattle, WA, USA., Sanders CM; Adaptive Biotechnologies, Seattle, WA, USA., Kawaguchi ES; Department of Biostatistics, Fielding School of Public Health, University of California, Los Angeles, Los Angeles, CA, USA., Du L; Department of Biostatistics, Fielding School of Public Health, University of California, Los Angeles, Los Angeles, CA, USA., Li G; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA.; Department of Biostatistics, Fielding School of Public Health, University of California, Los Angeles, Los Angeles, CA, USA., Yong WH; Department of Pathology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Gaffey SC; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Cohen AL; Department of Neurosurgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Mellinghoff IK; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lee EQ; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Reardon DA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., O'Brien BJ; Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Butowski NA; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Nghiemphu PL; Department of Neurology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Clarke JL; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA., Arrillaga-Romany IC; Department of Neurology, Massachusetts General Hospital Cancer Center, Boston, MA, USA., Colman H; Department of Neurosurgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Kaley TJ; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., de Groot JF; Department of Neuro-Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Liau LM; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA.; Department of Neurosurgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA., Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Prins RM; Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. rprins@mednet.ucla.edu.; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, Los Angeles, CA, USA. rprins@mednet.ucla.edu.; Department of Neurosurgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. rprins@mednet.ucla.edu.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. rprins@mednet.ucla.edu.
Publikováno v:
Nature medicine [Nat Med] 2019 Mar; Vol. 25 (3), pp. 477-486. Date of Electronic Publication: 2019 Feb 11.
Autor:
Tarhini A; UPMC Hillman Cancer Center, Pittsburgh, USA. tarhina1@ccf.org.; Department of Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute and Case Comprehensive Cancer Center, 9500 Euclid Ave CA6-157, Cleveland, OH, 44195, USA. tarhina1@ccf.org., Lin Y; UPMC Hillman Cancer Center, Pittsburgh, USA., Lin H; UPMC Hillman Cancer Center, Pittsburgh, USA., Rahman Z; UPMC Hillman Cancer Center, Pittsburgh, USA., Vallabhaneni P; UPMC Hillman Cancer Center, Pittsburgh, USA., Mendiratta P; Department of Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute and Case Comprehensive Cancer Center, 9500 Euclid Ave CA6-157, Cleveland, OH, 44195, USA., Pingpank JF; UPMC Hillman Cancer Center, Pittsburgh, USA., Holtzman MP; UPMC Hillman Cancer Center, Pittsburgh, USA., Yusko EC; Adaptive Biotechnologies, Seattle, USA., Rytlewski JA; Adaptive Biotechnologies, Seattle, USA., Rao UNM; UPMC Hillman Cancer Center, Pittsburgh, USA., Ferris RL; UPMC Hillman Cancer Center, Pittsburgh, USA., Kirkwood JM; UPMC Hillman Cancer Center, Pittsburgh, USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2018 Oct 23; Vol. 6 (1), pp. 112. Date of Electronic Publication: 2018 Oct 23.
Autor:
Patel N; Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA., McDonald ML; Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA., Bradford NS; Section on Cardiology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA., Smith JW; Section on Cardiology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA., Beaty EH; Section on Cardiology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA., Rytlewski JA; Section on Cardiology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA., Simmons TW; Section on Cardiology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA., Whalen P; Section on Cardiology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA., Zhao DX; Section on Cardiology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA., Bhave PD; Section on Cardiology, Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Publikováno v:
The Journal of innovations in cardiac rhythm management [J Innov Card Rhythm Manag] 2018 Aug 15; Vol. 9 (8), pp. 3291-3296. Date of Electronic Publication: 2018 Aug 15 (Print Publication: 2018).
Autor:
Hopkins AC; Johns Hopkins University, Sidney Kimmel Cancer Center, Skip Viragh Center for Pancreas Cancer, The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland, USA., Yarchoan M; Johns Hopkins University, Sidney Kimmel Cancer Center, Skip Viragh Center for Pancreas Cancer, The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland, USA., Durham JN; Johns Hopkins University, Sidney Kimmel Cancer Center, Skip Viragh Center for Pancreas Cancer, The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland, USA., Yusko EC; Adaptive Biotechnologies, Seattle, Washington, USA., Rytlewski JA; Adaptive Biotechnologies, Seattle, Washington, USA., Robins HS; Adaptive Biotechnologies, Seattle, Washington, USA., Laheru DA; Johns Hopkins University, Sidney Kimmel Cancer Center, Skip Viragh Center for Pancreas Cancer, The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland, USA., Le DT; Johns Hopkins University, Sidney Kimmel Cancer Center, Skip Viragh Center for Pancreas Cancer, The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland, USA., Lutz ER; Johns Hopkins University, Sidney Kimmel Cancer Center, Skip Viragh Center for Pancreas Cancer, The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland, USA., Jaffee EM; Johns Hopkins University, Sidney Kimmel Cancer Center, Skip Viragh Center for Pancreas Cancer, The Bloomberg-Kimmel Institute for Cancer Immunotherapy, Baltimore, Maryland, USA.
Publikováno v:
JCI insight [JCI Insight] 2018 Jul 12; Vol. 3 (13). Date of Electronic Publication: 2018 Jul 12.
Autor:
Wrangle JM; Department of Medicine, Division of Hematology and Oncology, and Department of Surgery Medical University of South Carolina, Charleston, SC, USA., Velcheti V; Cleveland Clinic, Cleveland, OH, USA., Patel MR; Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN, USA., Garrett-Mayer E; Department of Medicine, Division of Hematology and Oncology, and Department of Surgery Medical University of South Carolina, Charleston, SC, USA., Hill EG; Department of Medicine, Division of Hematology and Oncology, and Department of Surgery Medical University of South Carolina, Charleston, SC, USA., Ravenel JG; Department of Medicine, Division of Hematology and Oncology, and Department of Surgery Medical University of South Carolina, Charleston, SC, USA., Miller JS; Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN, USA., Farhad M; Earle A Chiles Research Institute, Portland, OR, USA., Anderton K; Department of Medicine, Division of Hematology and Oncology, and Department of Surgery Medical University of South Carolina, Charleston, SC, USA., Lindsey K; Department of Medicine, Division of Hematology and Oncology, and Department of Surgery Medical University of South Carolina, Charleston, SC, USA., Taffaro-Neskey M; Department of Medicine, Division of Hematology and Oncology, and Department of Surgery Medical University of South Carolina, Charleston, SC, USA., Sherman C; Department of Medicine, Division of Hematology and Oncology, and Department of Surgery Medical University of South Carolina, Charleston, SC, USA., Suriano S; Department of Medicine, Division of Hematology and Oncology, and Department of Surgery Medical University of South Carolina, Charleston, SC, USA., Swiderska-Syn M; Department of Medicine, Division of Hematology and Oncology, and Department of Surgery Medical University of South Carolina, Charleston, SC, USA., Sion A; Department of Medicine, Division of Hematology and Oncology, and Department of Surgery Medical University of South Carolina, Charleston, SC, USA., Harris J; Department of Medicine, Division of Hematology and Oncology, and Department of Surgery Medical University of South Carolina, Charleston, SC, USA., Edwards AR; Department of Medicine, Division of Hematology and Oncology, and Department of Surgery Medical University of South Carolina, Charleston, SC, USA., Rytlewski JA; Adaptive Biotechnologies, Seattle, WA, USA., Sanders CM; Adaptive Biotechnologies, Seattle, WA, USA., Yusko EC; Adaptive Biotechnologies, Seattle, WA, USA., Robinson MD; Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland., Krieg C; Department of Medicine, Division of Hematology and Oncology, and Department of Surgery Medical University of South Carolina, Charleston, SC, USA., Redmond WL; Earle A Chiles Research Institute, Portland, OR, USA., Egan JO; Altor BioScience, Miramar, FL, USA., Rhode PR; Altor BioScience, Miramar, FL, USA., Jeng EK; Altor BioScience, Miramar, FL, USA., Rock AD; Altor BioScience, Miramar, FL, USA., Wong HC; Altor BioScience, Miramar, FL, USA., Rubinstein MP; Department of Medicine, Division of Hematology and Oncology, and Department of Surgery Medical University of South Carolina, Charleston, SC, USA. Electronic address: markrubinstein@musc.edu.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2018 May; Vol. 19 (5), pp. 694-704. Date of Electronic Publication: 2018 Apr 05.